Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: Design, optimization, in vitro and in vivo evaluation

Journal of Molecular Liquids

Volumn 218, Issue , 2016, Pages 219-232

  Kassem, Ahmed Alaa ^a   Mohsen, Amira Mohamed ^a   Ahmed, Reham Samir ^b   Essam, Tamer Mohamed ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Immunosuppressed mouse model; Nystatin; Oral candidiasis; Poorly water soluble drug; Pseudo ternary phase diagram; Self nanoemulsifying drug delivery system (SNEDDS)

Indexed keywords

BIOCHEMISTRY; DIMETHYL SULFOXIDE; FUNGI; MAGNETIC LEVITATION VEHICLES; OLEIC ACID; ORGANIC SOLVENTS; PHASE DIAGRAMS; SURFACE ACTIVE AGENTS; TERNARY ALLOYS;

MOUSE MODELS; NYSTATIN; ORAL CANDIDIASIS; POORLY WATER-SOLUBLE DRUGS; PSEUDOTERNARY PHASE DIAGRAMS; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS);

SOLUBILITY;

EID: 84959520085     PISSN: 01677322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molliq.2016.02.081     Document Type: Article

References (95)

1. S. Pal, S. Nagy, T. Bozo, B. Kocsis, and A. Devay Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system Eur. J. Pharm. Sci. 49 2013 258 264
2. L.L. Patton, A.J. Bonito, and D.A. Shugars A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 92 2001 170 179
3. A. Akpan, and R. Morgan Oral candidiasis Postgrad. Med. J. 78 2002 455 459
4. H. Gonzalez Gravina, E. Gonzalez de Moran, O. Zambrano, M. Lozano Chourio, S. Rodriguez de Valero, S. Robertis, and L. Mesa Oral candidiasis in children and adolescents with cancer. Identification of Candida spp Med. Oral Patol. Oral Cir. Bucal 12 2007 E419 E423
5. A. Melkoumov, M. Goupil, F. Louhichi, M. Raymond, L. de Repentigny, and G. Leclair Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans J. Antimicrob. Chemother. 68 2013 2099 2105
6. B. Spellberg Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge PLoS Pathog. 4 2008 e38
7. R. Lopez-Martinez Candidosis, a new challenge Clin. Dermatol. 28 2010 178 184
8. M.J. Martin, A.C. Calpena, F. Fernandez, M. Mallandrich, P. Galvez, and B. Clares Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery Carbohydr. Polym. 117 2015 140 149
9. J.A. Ship, A. Vissink, and S.J. Challacombe Use of prophylactic antifungals in the immunocompromised host Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103 2007 (Suppl., S6 e1-14)
10. P.G. Pappas Invasive candidiasis Infect. Dis. Clin. N. Am. 20 2006 485 506
11. D. Marin-Quintero, F. Fernandez-Campos, A.C. Calpena-Campmany, M.J. Montes-Lopez, B. Clares-Naveros, and A. Del Pozo-Carrascosa Formulation design and optimization for the improvement of nystatin-loaded lipid intravenous emulsion J. Pharm. Sci. 102 2013 4015 4023
12. A. Coutinho, and M. Prieto Cooperative partition model of nystatin interaction with phospholipid vesicles Biophys. J. 84 2003 3061 3078
13. A.N. Ellepola, and L.P. Samaranayake The in vitro post-antifungal effect of nystatin on Candida species of oral origin J. Oral Pathol. Med. 28 1999 112 116
14. Nystatin British Pharmacopoeia 2007 1497 1498
15. G.K. Mc Evoy Nystatin Drug Information 2004 American Society of Health-System Pharmacists, American Hospital Formulary Service (AHFS) 528 529
16. S.C. Sweetman Nystatin Martindale 2009 The Complete Drug Reference, Pharmaceutical Press London, Chicago 543 544
17. I.P. Kaur, and S. Kakkar Topical delivery of antifungal agents Expert Opin. Drug Deliv. 7 2010 1303 1327
18. S.R. Croy, and G.S. Kwon The effects of pluronic block copolymers on the aggregation state of nystatin J. Control. Release 95 2004 161 171
19. F. Fernandez-Campos, B. Clares Naveros, O. Lopez Serrano, C. Alonso Merino, and A.C. Calpena Campmany Evaluation of novel nystatin nanoemulsion for skin candidosis infections Mycoses 56 2012 70 81
20. J. Bolard, P. Legrand, F. Heitz, and B. Cybulska One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium Biochemistry 30 1991 5707 5715
21. J.M. Llabot, R.H. Manzo, and D.A. Allemandi Double-layered mucoadhesive tablets containing nystatin AAPS PharmSciTech 3 2002 E22
22. K. Sakeer, H. Al-Zein, I. Hassan, S. Desai, and A. Nokhodchi Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation Arch. Pharm. Res. 33 2010 1771 1779
23. A.W. Ng, K.M. Wasan, and G. Lopez-Berestein Development of liposomal polyene antibiotics: an historical perspective J. Pharm. Pharm. Sci. 6 2003 67 83
24. M.S. El-Ridy, A. Abdelbary, T. Essam, R.M. El-Salam, and A.A. Kassem Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin Drug Dev. Ind. Pharm. 37 2011 1491 1508
25. F. Fernandez-Campos, A.C. Calpena Campmany, G. Rodriguez Delgado, O. Lopez Serrano, and B. Clares Naveros Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies J. Pharm. Sci. 101 2012 3739 3752
26. R. Semis, I. Polacheck, and E. Segal Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds Mycopathologia 169 2010 333 341
27. M.J. Martin-Villena, F. Fernandez-Campos, A.C. Calpena-Campmany, N. Bozal-de Febrer, M.A. Ruiz-Martinez, and B. Clares-Naveros Novel microparticulate systems for the vaginal delivery of nystatin: development and characterization Carbohydr. Polym. 94 2013 1 11
28. R. Khalil, M. Kassem, A. Abdelbary, M. El-Ridy, and M. AbouSamra Preparation and characterization of nystatin-loaded solid lipid nanoparticles for topical delivery Int. J. Pharm. Sci. Res. 4 2013 2292 2300
29. R.M. Khalil, A. Abdelbary, M.A. Kassem, M.S. El-Ridy, M.M. Abou Samra, G.E.A. Awad, and S.S. Mansy Formulation and characterization of nystatin-loaded nanostructured lipid carriers for topical delivery against cutaneous candidiasis Br. J. Pharm. Res. 4 2014 490 512
30. D. Sakloetsakun, S. Dunnhaupt, J. Barthelmes, G. Perera, and A. Bernkop-Schnurch Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration Int. J. Biol. Macromol. 61 2013 363 372
31. N. Parmar, N. Singla, S. Amin, and K. Kohli Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system Colloids Surf. B: Biointerfaces 86 2011 327 338
32. P.P. Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm. Res. 12 1995 1561 1572
33. K. Balakumar, C.V. Raghavan, N.T. Selvan, R.H. Prasad, and S. Abdu Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation Colloids Surf. B: Biointerfaces 112 2013 337 343
34. N. Heshmati, X. Cheng, G. Eisenbrand, and G. Fricker Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats J. Pharm. Sci. 102 2013 3792 3799
35. K. Kohli, S. Chopra, D. Dhar, S. Arora, and R.K. Khar Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability Drug Discov. Today 15 2010 958 965
36. N. Thomas, R. Holm, M. Garmer, J.J. Karlsson, A. Mullertz, and T. Rades Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs AAPS J. 15 2013 219 227
37. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh Lipid - an emerging platform for oral delivery of drugs with poor bioavailability Eur. J. Pharm. Biopharm. 73 2009 1 15
38. J. Xi, Q. Chang, C.K. Chan, Z.Y. Meng, G.N. Wang, J.B. Sun, Y.T. Wang, H.H. Tong, and Y. Zheng Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid AAPS PharmSciTech 10 2009 172 182
39. L. Wang, J. Dong, J. Chen, J. Eastoe, and X. Li Design and optimization of a new self-nanoemulsifying drug delivery system J. Colloid Interface Sci. 330 2009 443 448
40. R.N. Gursoy, and S. Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 58 2004 173 182
41. P.P. Constantinides, J.P. Scalart, C. Lancaster, J. Marcello, G. Marks, H. Ellens, and P.L. Smith Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides Pharm. Res. 11 1994 1385 1390
42. A. Bernkop-Schnurch Nanocarrier systems for oral drug delivery: do we really need them? Eur. J. Pharm. Sci. 49 2013 272 277
43. U.A. Fahmy, O.A. Ahmed, and K.M. Hosny Development and evaluation of avanafil self-nanoemulsifying drug delivery system with rapid onset of action and enhanced bioavailability AAPS PharmSciTech 16 2015 53 58
44. A.A. Date, and M.S. Nagarsenker Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil Int. J. Pharm. 329 2007 166 172
45. Y.S. Elnaggar, M.A. El-Massik, and O.Y. Abdallah Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization Int. J. Pharm. 380 2009 133 141
46. E.B. Basalious, N. Shawky, and S.M. Badr-Eldin SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization Int. J. Pharm. 391 2010 203 211
47. S. Beg, S. Swain, H.P. Singh, N. Patra Ch, and M.E. Rao Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers AAPS PharmSciTech 13 2012 1416 1427
48. F. Shakeel, N. Haqa, F.K. Alanazi, and I.A. Alsarra Polymeric solid self-nanoemulsifying drug delivery system of glibenclamide using coffee husk as a low cost biosorbent Powder Technol. 256 2014 352 360
49. A.G. Agrawal, A. Kumar, and P.S. Gide Formulation of solid self-nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent Drug Dev. Ind. Pharm. 41 2015 594 604
50. P. Zhang, Y. Liu, N. Feng, and J. Xu Preparation and evaluation of self-microemulsifying drug delivery system of oridonin Int. J. Pharm. 355 2008 269 276
51. M. El-Badry, N. Haq, G. Fetih, and F. Shakeel Solubility and dissolution enhancement of tadalafil using self-nanoemulsifying drug delivery system J. Oleo Sci. 63 2014 567 576
52. S. Zargar-Shoshtari, J. Wen, and R.G. Alany Formulation and physicochemical characterization of imwitor 308 based self microemulsifying drug delivery systems Chem. Pharm. Bull. 58 2010 1332 1338
53. K.M. Hosny, and Z.M. Banjar The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia Expert Opin. Drug Deliv. 10 2013 1033 1041
54. A.K. Singh, A. Chaurasiya, A. Awasthi, G. Mishra, D. Asati, R.K. Khar, and R. Mukherjee Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS) AAPS PharmSciTech 10 2009 906 916
55. R. Yang, X. Huang, J. Dou, G. Zhai, and L. Su Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation Int. J. Nanomedicine 8 2013 2917 2926
56. C.S. Chaw, K.W. Chooi, X.M. Liu, C.W. Tan, L. Wang, and Y.Y. Yang Thermally responsive core-shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides: drug incorporation and in vitro release Biomaterials 25 2004 4297 4308
57. J.M. Llabot, R.H. Manzo, and D.A. Allemandi Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance J. Pharm. Sci. 98 2009 1871 1876
58. K. Sakeer, H. Al-Zein, I. Hassan, G.P. Martin, and A. Nokhodchi Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets Pharm. Dev. Technol. 15 2010 360 368
59. J.M. Andrews Determination of minimum inhibitory concentrations J. Antimicrob. Chemother. 48 Suppl. 1 2001 5 16
60. C.J. Clancy, H. Huang, S. Cheng, H. Derendorf, and M.H. Nguyen Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments Antimicrob. Agents Chemother. 50 2006 2569 2572
61. N. Takakura, H. Wakabayashi, H. Ishibashi, S. Teraguchi, Y. Tamura, H. Yamaguchi, and S. Abe Oral lactoferrin treatment of experimental oral candidiasis in mice Antimicrob. Agents Chemother. 47 2003 2619 2623
62. K. Ninomiya, N. Maruyama, S. Inoue, H. Ishibashi, T. Takizawa, H. Oshima, and S. Abe The essential oil of Melaleuca alternifolia (tea tree oil) and its main component, terpinen-4-ol protect mice from experimental oral candidiasis Biol. Pharm. Bull. 35 2012 861 865
63. M.M. Badran, E.I. Taha, M.M. Tayel, and S.A. Al-Suwayeh Ultra-fine self nanoemulsifying drug delivery system for transdermal delivery of meloxicam: dependency on the type of surfactants J. Mol. Liq. 190 2014 16 22
64. X. Qi, L. Wang, J. Zhu, Z. Hu, and J. Zhang Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability Int. J. Pharm. 409 2011 245 251
65. Y. Onuki, M. Morishita, and K. Takayama Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery J. Control. Release 97 2004 91 99
66. M. Verbrugghe, E. Cocquyt, P. Saveyn, P. Sabatino, D. Sinnaeve, J.C. Martins, and P. Van der Meeren Quantification of hydrophilic ethoxylates in polysorbate surfactants using diffusion H1 NMR spectroscopy J. Pharm. Biomed. Anal. 51 2010 583 589
67. P.R. Nepal, H.K. Han, and H.K. Choi Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10) Eur. J. Pharm. Sci. 39 2010 224 232
68. T.R. Kommuru, B. Gurley, M.A. Khan, and I.K. Reddy Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment Int. J. Pharm. 212 2001 233 246
69. S. Shafiq, F. Shakeel, S. Talegaonkar, F.J. Ahmad, R.K. Khar, and M. Ali Development and bioavailability assessment of ramipril nanoemulsion formulation Eur. J. Pharm. Biopharm. 66 2007 227 243
70. C.W. Pouton, and C.J. Porter Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies Adv. Drug Deliv. Rev. 60 2008 625 637
71. Y. Zhao, C. Wang, A.H. Chow, K. Ren, T. Gong, Z. Zhang, and Y. Zheng Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of zedoary essential oil: formulation and bioavailability studies Int. J. Pharm. 383 2010 170 177
72. M. Rizwan, M. Aqil, A. Azeem, S. Talegaonkar, Y. Sultana, and A. Ali Enhanced transdermal delivery of carvedilol using nanoemulsion as a vehicle J. Exp. Nanosci. 5 2010 390 411
73. M.J. Lawrence, and G.D. Rees Microemulsion-based media as novel drug delivery systems Adv. Drug Deliv. Rev. 45 2000 89 121
74. A.R. Dixit, S.J. Rajput, and S.G. Patel Preparation and bioavailability assessment of SMEDDS containing valsartan AAPS PharmSciTech 11 2010 314 321
75. C.W. Pouton Formulation of self emulsifying drug delivery systems Adv. Drug Deliv. Rev. 25 1997 47 58
76. M.J. Rang, and C.A. Miller Spontaneous emulsification of oils containing hydrocarbon, nonionic surfactant, and oleyl alcohol J. Colloid Interface Sci. 209 1999 179 192
77. S. Shafiq, F. Shakeel, S. Talegaonkar, F.J. Ahmad, R.K. Khar, and M. Ali Design and development of oral oil in water ramipril nanoemulsion formulation: in vitro and in vivo assessment J. Biomed. Nanotechnol. 3 2007 28 44
78. F. Shakeel, N. Haq, M. Elbadry, F.K. Alanazi, and I.A. Alsarra Ultra fine super self-nanoemulsifying drug delivery system (SNEDDS) enhanced solubility and dissolution of indomethacin J. Mol. Liq. 180 2013 89 94
79. S.K. Singh, P.R. Verma, and B. Razdan Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization Drug Dev. Ind. Pharm. 36 2010 933 945
80. S. Kanuganti, R. Jukanti, P.R. Veerareddy, and S. Bandari Paliperidone-loaded self-emulsifying drug delivery systems (SEDDS) for improved oral delivery J. Dispers. Sci. Technol. 33 2012 506 515
81. C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S93 S98
82. K. Itoh, Y. Tozuka, T. Oguchi, and K. Yamamoto Improvement of physicochemical properties of N-4472 part I formulation design by using self-microemulsifying system Int. J. Pharm. 238 2002 153 160
83. R.M. Hathout, T.J. Woodman, S. Mansour, N.D. Mortada, A.S. Geneidi, and R.H. Guy Microemulsion formulations for the transdermal delivery of testosterone Eur. J. Pharm. Sci. 40 2010 188 196
84. R.C. Baker, A.T. Florence, R.H. Ottewill, and T.F. Tadros Investigations into the formation and characterization of microemulsions. II. Light scattering conductivity and viscosity studies of microemulsions J. Colloid Interface Sci. 100 1984 332 349
85. A.K. Singh, A. Chaurasiya, M. Singh, S.C. Upadhyay, R. Mukherjee, and R.K. Khar Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization AAPS PharmSciTech 9 2008 628 634
86. N.H. Shah, M.T. Carvagal, C.I. Patel, M.H. Infeld, and A.W. Malick Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs Int. J. Pharm. 106 1994 15 23
87. K.O. Choi, N.P. Aditya, and S. Ko Effect of aqueous pH and electrolyte concentration on structure, stability and flow behavior of non-ionic surfactant based solid lipid nanoparticles Food Chem. 147 2014 239 244
88. W. Wu, Y. Wang, and L. Que Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system Eur. J. Pharm. Biopharm. 63 2006 288 294
89. N. Thomas, A. Mullertz, A. Graf, and T. Rades Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems J. Pharm. Sci. 101 2012 1721 1731
90. R.M. Lopez, A. Ayestaran, L. Pou, J.B. Montoro, M. Hernandez, and I. Caragol Stability of amphotericin B in an extemporaneously prepared i.v. fat emulsion Am. J. Health Syst. Pharm. 53 1996 2724 2727
91. P.J. Dentinger, C.F. Swenson, and N.H. Anaizi Stability of amphotericin B in an extemporaneously compounded oral suspension Am. J. Health Syst. Pharm. 58 2001 1021 1024
92. J. Groeschke, I. Solassol, F. Bressolle, and F. Pinguet Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate J. Pharm. Biomed. Anal. 42 2006 362 366
93. H. van Doorne, and E.H. Bosch Stability and in vitro activity of nystatin and its y-cyclodextrin complex against Candida albicans Int. J. Pharm. 73 1991 43 49
94. N. Vermerie, C. Malbrunot, M. Azar, and P. Arnaud Stability of nystatin in mouthrinses; effect of pH temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity Pharm. World Sci. 19 1997 197 201
95. A. Martinez, J. Regadera, E. Jimenez, I. Santos, and D. Gargallo-Viola Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats Antimicrob. Agents Chemother. 45 2001 1008 1013